This company has been acquired
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Prometheus Biosciences Dividend
Dividend criteriumcontroles 0/6
Prometheus Biosciences does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
n/a
Uitbetalingsratio
Gemiddelde opbrengst industrie | 1.9% |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Winst per aandeel | -US$3.15 |
Dividendrendementsvoorspelling | 0% |
Recente dividendupdates
Geen updates
Recent updates
We Think Prometheus Biosciences (NASDAQ:RXDX) Can Afford To Drive Business Growth
May 17Here's Why We're Not Too Worried About Prometheus Biosciences' (NASDAQ:RXDX) Cash Burn Situation
Dec 03We Think Prometheus Biosciences (NASDAQ:RXDX) Needs To Drive Business Growth Carefully
Aug 19Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06, revenue of $1.26M beats by $0.8M
Aug 11We're Hopeful That Prometheus Biosciences (NASDAQ:RXDX) Will Use Its Cash Wisely
May 04Prometheus: Biotech To Watch With A Monoclonal Antibody For Immune-Mediated Diseases
Dec 08Prometheus Biosciences (NASDAQ:RXDX) Is In A Good Position To Deliver On Growth Plans
Nov 16Prometheus Biosciences: Precision Medicine For IBD
Sep 22Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if RXDX's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if RXDX's dividend payments have been increasing.
Dividendrendement versus markt
Prometheus Biosciences Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (RXDX) | n/a |
Markt onderkant 25% (US) | 1.4% |
Markt Top 25% (US) | 4.4% |
Gemiddelde industrie (Biotechs) | 1.9% |
Analist prognose (RXDX) (tot 3 jaar) | 0% |
Opmerkelijk dividend: Unable to evaluate RXDX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate RXDX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as RXDX has not reported any payouts.